The effect of vardenafil was not modified by co-treatment with a PKG (Fig. 3B9) or PKA (Fig. 3B10) inhibitor in CF cells, indicating that the increased CFTR intracellular accumulation upon vardenafil treatment is not related to the PK signalling cascades triggered by the cGMP increase. This evidence concerns the gene CFTR and cystic fibrosis.